Crohn's
Managing and Maintaining Clinical Response in Moderately to Severely Active Crohn’s Disease: Efficacy and Safety of CIMZIA® (Certolizumab Pegol)
The increase in treatment options has been an important advance for the goal of achieving a sustained remission in ...
APRIL 14, 2023
Regueiro Report: Picks From CCC, Part 2
In this installment, Dr. Regueiro highlights three more abstracts from the 2022 Crohn’s & Colitis ...
MAY 19, 2022
Regueiro Report: Picks From the Crohn’s & Colitis Congress, Part 1
We now have more medicines in our inflammatory bowel disease clinical armamentarium than ever before.
APRIL 25, 2022
Medication Linked to Increased Risk for IBD
Medications that target tumor necrosis factor-alpha (TNF-alpha), a protein involved in inflammation, have ...
SEPTEMBER 5, 2019
Anti-MAP Treatment Tops Placebo in Large Crohn’s Trial
New research is adding support to the controversial theory that Mycobacterium avium subspecies paratuberculosis ...
FEBRUARY 4, 2019
Vedolizumab Bests Anti-TNF Treatments in Real-World Setting
People with inflammatory bowel disease treated with vedolizumab monotherapy are almost half as likely as those who ...
MAY 15, 2018
Microbial Changes Precipitate a Crohn’s Relapse
Changes in the microbiota of a person with Crohn’s disease during remission may predict a recurrence of ...
MAY 9, 2018
Peds With Crohn’s, Colitis Benefit From Fecal Transplant
Fecal transplant is an effective way to treat Crohn’s disease or ulcerative colitis in children, researchers ...
NOVEMBER 27, 2017
Sherman Prize Announces 2017 Award Recipients
Three leaders in the field of inflammatory bowel disease received this year’s Sherman Prize for their ...
OCTOBER 24, 2017
Study: When Effective, Ustekinumab ‘Likely to Work Well For a Long Duration’
Patients with Crohn’s disease who experience an initial response to ustekinumab are likely to maintain ...
JUNE 19, 2017
Ustekinumab 'Likely to Work Well for Long Duration,' New Data Suggest
Patients with Crohn's disease who experience an initial response to ustekinumab are likely to maintain response ...
MAY 15, 2017
Research Links Microbiome Makeup To Remission in Pediatric Crohn’s
Montreal—Early changes in microbial community structure are associated with sustained remission after ...
APRIL 27, 2017
